More Than Looks: Exploring Methods to Test Phonological Discrimination in the Sign Language Kata Kolok.

The lack of diversity in the language sciences has increasingly been criticized as it holds the potential for producing flawed theories. Research on (i) geographically diverse language communities and (ii) on sign languages is necessary to corroborate, sharpen, and extend existing theories. This study contributes a case study of adapting a well-established paradigm to study the acquisition of sign phonology in Kata Kolok, a sign language of rural Bali, Indonesia.

A cross-linguistic examination of young children's everyday language experiences.

We present an exploratory cross-linguistic analysis of the quantity of target-child-directed speech and adult-directed speech in North American English (US & Canadian), United Kingdom English, Argentinian Spanish, Tseltal (Tenejapa, Mayan), and Yélî Dnye (Rossel Island, Papuan), using annotations from 69 children aged 2-36 months. Using a novel methodological approach, our cross-linguistic and cross-cultural findings support prior work suggesting that target-child-directed speech quantities are stable across early development, while adult-directed speech decreases. A preponderance of speech from women was found to a similar degree across groups, with less target-child-directed speech from men and children in the North American samples than elsewhere.

Daylong egocentric recordings in small- and large-scale language communities: A practical introduction.

Daylong egocentric (i.e., participant-centered) recordings promise an unprecedented view into the experiences that drive early language learning, impacting both assumptions and theories about how learning happens.

Everyday language input and production in 1,001 children from six continents.

Language is a universal human ability, acquired readily by young children, who otherwise struggle with many basics of survival. And yet, language ability is variable across individuals. Naturalistic and experimental observations suggest that children's linguistic skills vary with factors like socioeconomic status and children's gender.

Characterization of children's verbal input in a forager-farmer population using long-form audio recordings and diverse input definitions.

There is little systematically collected quantitative empirical data on how much linguistic input children in small-scale societies encounter, with some estimates suggesting low levels of directed speech. We report on an ecologically-valid analysis of speech experienced over the course of a day by young children (N = 24, 6-58 months old, 33% female) in a forager-horticulturalist population of lowland Bolivia. A permissive definition of input (i.

Long-term optical imaging of the spinal cord in awake, behaving animals.

Advances in optical imaging approaches and fluorescent biosensors have enabled an understanding of the spatiotemporal and long-term neural dynamics in the brain of awake animals. However, methodological difficulties and the persistence of post-laminectomy fibrosis have greatly limited similar advances in the spinal cord. To overcome these technical obstacles, we combined application of fluoropolymer membranes that inhibit fibrosis; a redesigned, cost-effective implantable spinal imaging chamber; and improved motion correction methods that together permit imaging of the spinal cord in awake, behaving mice, for months to over a year.

Combining observational and experimental approaches to the development of language and communication in rural samples: Opportunities and challenges.

Multiple approaches - including observational and experimental - are necessary to articulate powerful theories of learning. Our field's key questions, which rely on these varied methods, are still open. How do children perceive and produce language? What do they encounter in their linguistic input? What does the learner bring to the task of acquisition? Considerable progress has been made for the development of spoken English (especially by North American learners).

Immature Vocalizations Simplify the Speech of Tseltal Mayan and U.S. Caregivers.

What is the function of immature vocalizing in early learning environments? Previous work on infants in the United States indicates that prelinguistic vocalizations elicit caregiver speech which is simplified in its linguistic structure. However, there is substantial cross-cultural variation in the extent to which children's vocalizations elicit responses from caregivers. In the current study, we ask whether children's vocalizations elicit similar changes in their immediate caregivers' speech structure across two cultural sites with differing perspectives on how to interact with infants and young children.

Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trials.

Background: In adults with atopic dermatitis (AD), head and/or neck involvement is frequent, bothersome, and impacts quality of life, however, long-term topical corticosteroids (TCS) are contraindicated for this difficult-to-treat region. Baricitinib, an oral, selective, reversible inhibitor of Janus kinase 1/2 has demonstrated efficacy in adult patients with moderate-to-severe AD.

Objectives: For this post hoc analysis, data from five Phase III trials were used to investigate the efficacy of baricitinib in patients with head and neck involvement.

Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study.

Background: Skin pain (discomfort/soreness) is a common symptom associated with atopic dermatitis (AD).

Objective: To evaluate rapid changes in skin pain severity with baricitinib, and its impact on patient quality of life (QoL) in adults with moderate-to-severe AD who were inadequate responders to topical therapy.

Methods: Adult patients with moderate-to-severe AD who were inadequate responders to topical therapies ( = 440, BREEZE-AD5 [NCT03435081]) were randomized to once-daily placebo, baricitinib 1 mg, or baricitinib 2 mg for 16 weeks.

Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5).

Background: Itch and sleep disturbance due to itch are burdensome symptoms associated with atopic dermatitis (AD). Rapid onset of action is important for AD treatments to improve quality of life and relieve suffering.

Objectives: This subanalysis evaluated how quickly baricitinib 1-mg and 2-mg reduced itch and associated sleep disturbance during the first 7 days after treatment initiation in a phase 3, double-blind, placebo-controlled trial.

Alvimopan retains efficacy in patients undergoing colorectal surgery within an established ERAS program.

Background: Post-operative ileus and delayed return of gastrointestinal function are complications seen frequently in patients undergoing colorectal surgery. Many enhanced recovery after surgery protocols include alvimopan to inhibit the effects of opiates in the gastrointestinal tract and lidocaine to augment analgesics. Limited data exist regarding alvimopan's efficacy in opiate-sparing regimens.

English-Speaking Adults' Labeling of Child- and Adult-Directed Speech Across Languages and Its Relationship to Perception of Affect.

Child-directed speech, as a specialized form of speech directed toward young children, has been found across numerous languages around the world and has been suggested as a universal feature of human experience. However, variation in its implementation and the extent to which it is culturally supported has called its universality into question. Child-directed speech has also been posited to be associated with expression of positive affect or "happy talk.

Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7.

Introduction: Skin pain (described as discomfort or soreness) is increasingly recognized as a symptom of atopic dermatitis which impacts patient quality of life. This analysis examined the effect of baricitinib on skin pain in atopic dermatitis in three phase 3 studies (BREEZE-AD1, -AD2, and -AD7).

Methods: Patients were randomly assigned 2:1:1:1 to receive once-daily placebo, baricitinib 1 mg, 2 mg, or 4 mg in BREEZE-AD1 (N = 624) and -AD2 (N = 615) and 1:1:1 to receive once-daily placebo, baricitinib 2 mg, or 4 mg, with topical corticosteroids, in BREEZE-AD7 (N = 329) for 16 weeks.

Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy.

Background: Baricitinib previously demonstrated improvements in itch and sleep disturbance versus placebo in adults with moderate-to-severe atopic dermatitis (AD).

Objectives: Examine if itch and sleep improvements are associated with better quality of life (QoL) and productivity in patients with AD.

Methods: Data were drawn from BREEZE-AD5 (NCT03435081).

Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies.

Introduction: Burdensome symptoms of atopic dermatitis include itch and sleep disturbance. This post hoc analysis reports the effect of baricitinib on itch and sleep disturbance during the first week of treatment in 3 phase 3 studies.

Methods: Patients were randomized 2:1:1:1 to once-daily placebo or baricitinib 1 mg, 2 mg, or 4 mg in the BREEZE-AD1 and -AD2 studies and 1:1:1 to once-daily placebo or baricitinib 2 mg or 4 mg in the BREEZE-AD7 study.